Glucosamine Knee Osteoarthritis Meta-analysis: What the Evidence Says
Glucosamine Knee Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Quick Answer
Glucosamine Knee Osteoarthritis Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 randomized trial, 1 narrative review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Glucosamine Knee Osteoarthritis Meta-analysis: What the Evidence Says
Quick Answer
Glucosamine Knee Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial | randomized trial | 2 | 2026-03-03 | 10.1186/s13063-026-09594-7 |
| Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges | narrative review | 3 | 2025-11-18 | 10.1021/acsptsci.5c00521 |
What The Sources Report
- Exercise improves balance, reduces fall risk, enhance walking function and postural control, alleviates pain and improves mobility. [Čeh Tina (2026); evidence level 2]
- Consumption of dietary supplements, such as glucosamine, is common in KOA treatment, though the clinical benefits remain inconclusive with conflicting evidence regarding their effectiveness and recommendations. [Čeh Tina (2026); evidence level 2]
- ,, d d N Figure Chondroitin sulfate (CS) is an anionic, sulfated glycosaminoglycan found in various connective tissues, including cartilage, bone, ligaments, tendons, and skin. [Silva Vitor Alfredo de Santana (2025); evidence level 3]
- In terrestrial animals, it is predominantly found as monosulfated disaccharides at the 4-O or 6-O positions of GalNAc (CS-A and CS-C, respectively), along with a small percentage of nonsulfated disaccharides (CS-0). [Silva Vitor Alfredo de Santana (2025); evidence level 3]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is trial evidence in the current set, but population and intervention details still matter. For glucosamine knee osteoarthritis meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Čeh Tina (2026). Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial. DOI: 10.1186/s13063-026-09594-7. PMCID: PMC13063509. PMID: 41772729. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13063509/
- Silva Vitor Alfredo de Santana (2025). Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges. DOI: 10.1021/acsptsci.5c00521. PMCID: PMC12707266. PMID: 41409165. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12707266/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed May 28, 2026 by Migaku Evidence Review
